Objectives To evaluate the efficacy of rituximab (RTX) in IgG4-related disease (IgG4-RD) in an open-label pilot trial. Methods We treated 30 IgG4-RD patients with two doses of RTX (1000 mg each). The ...
After hours: December 10 at 4:02:46 PM EST ...
The company is now waiting for the results of the INDIGO trial in IgG4-RD in 2025, aiming to become the first FDA-approved treatment for the progressive, fibroinflammatory disease, which can cause ...
Nov. 25, 2024 — A new computer model can be used to detect and measure interior oceans on the ice covered moons of Uranus. The model works by analyzing orbital wobbles that would be visible from ...
A complete smart security system beyond the camera is the best way to make sure your home is completely secured. But security systems are different from security cameras. Here’s the difference ...
Diseases of the nervous system refer to disorders that affect any part of the central nervous system (brain, spinal cord or cranial nerves) or peripheral nervous system. Substance-use disorders ...
A key phase 3 readout in immune thrombocytopenia is due later this year, along with phase 2 results in asthma, IgG4-related disease, and warm autoimmune haemolytic anaemia, and phase 3 testing in ...
Yet another fun, bright and colorful holiday tradition is back in Bend: Brightly lit kayaks, canoes and paddle boards will light up the Deschutes… ...
After hours: December 10 at 4:02:51 PM EST Loading Chart for CENT ...
It consists of nerves that carry information between the central nervous system and the extremities of the body. We used single-soma deep RNA sequencing to generate a high-resolution atlas of ...
Pterodactyl® is a free, open-source game server management panel built with PHP, React, and Go. Designed with security in mind, Pterodactyl runs all game servers in isolated Docker containers while ...
Issued at 4:25 pm EDT on Friday 13 December 2024 for the period until midnight EDT Friday 20 December 2024. For latest warnings go to www.bom.gov.au, subscribe to RSS feeds, call 1300 659 210* or ...